Science Summit at United Nations General Assembly 77 (UNGA77)

PROGRAM
8:15 Opening
Chairmans:
Jorge Rico F., MD (COL)
Guillermo Alvarez E., MD (DOM)

8:30 – 9:00 a.m.
Chronic Kidney Disease in the Americas: a growing pandemic
Guillermo Alvarez E., MD (DOM)

9:00 – 9:30 a.m.
Chronic Kidney Disease of undetermined cause in the Americas: a growing shadow pandemic
Ramón García Trabanino, MD (SAL)

9:40 – 11:10 a.m.
The importance of CKD Registries for decision-making in health. The Latin American Registry of Dialysis and Transplantation:
History
Contribution to knowledge
Challenges
Maria Carlota Gonzalez Bedat (URU)

The SLANH-OPS alliance
Alejandro Ferreiro Fuentes (URU)

Epidemiological data of CKD in RRT in LATAM
Maria Carlota Gonzalez Bedat (URU)

Examples of decision-making based on data from ERC Registries
Guillermo Rosa Diez (ARG)

11:20 a.m. – 11:40 p.m.
CKD in a situation of health inertia in Latin America
Augusto Vallejos, MD (ARG)

11:40 a.m. - 12:00 p.m.
Recommendations for the creation of a Renal Health Program in Latin America. 
Cristina Carlino, MD (ARG)

12:00 p.m. - 12:20 p.m.
18 years of the Renal Health Program of Uruguay
Pablo Rios, MD (URU)

12:20 p.m. - 12:40 p.m. 
Renal Health in RED in Chile
Carlos Zuñiga, MD (CHI)

12:40 p.m. - 01:00 p.m. 
Other successful experiences in LA.Guatemala
Vicente Sanchez Polo, MD (GUA)

01:00 p.m.- 01:30 p.m.
Q&A

03:00 p.m. – 3:30 p.m.
Financial burden of Chronic Kidney Disease for health systems
The global burden of chronic kidney disease in Latin America, its impact on the generation of a Health policy and decision making for Renal Substitution therapies
Chairman: Laura Cortes Sanabria, MD (MEX)

Inequity in renal care in Latin America. The effects of economic variables and post-pandemic challenges
Sebastian Cabrera, MD (CHI)

Importance of the study of the global burden of CKD for decision-making in renal health policy in Latin America.
Javier Arango, MD (COL)

Cost effectiveness studies a tool to generate valuable results in the availability of renal replacement therapies in Latin America.
Santiago Torales, MD (ARG)

3:30 p.m. – 4:00 p.m.
Conclusions